102 related articles for article (PubMed ID: 1422320)
21. Effects of ipriflavone on bone loss following a bilateral ovariectomy and menopause: a randomized placebo-controlled study.
Katase K; Kato T; Hirai Y; Hasumi K; Chen JT
Calcif Tissue Int; 2001 Aug; 69(2):73-7. PubMed ID: 11683426
[TBL] [Abstract][Full Text] [Related]
22. Effects of ipriflavone on postmenopausal syndrome and osteoporosis.
Zhang X; Li SW; Wu JF; Dong CL; Zheng CX; Zhang YP; Du J
Gynecol Endocrinol; 2010 Feb; 26(2):76-80. PubMed ID: 19672742
[TBL] [Abstract][Full Text] [Related]
23. Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.
Agnusdei D; Zacchei F; Bigazzi S; Cepollaro C; Nardi P; Montagnani M; Gennari C
Drugs Exp Clin Res; 1989; 15(2):97-104. PubMed ID: 2661184
[TBL] [Abstract][Full Text] [Related]
24. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
Gennari C; AgnusDei D; Gonnelli S; Nardi P
Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
[TBL] [Abstract][Full Text] [Related]
25. Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis.
Thiébaud D; Burckhardt P; Kriegbaum H; Huss H; Mulder H; Juttmann JR; Schöter KH
Am J Med; 1997 Oct; 103(4):298-307. PubMed ID: 9382122
[TBL] [Abstract][Full Text] [Related]
26. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.
Devogelaer JP; Broll H; Correa-Rotter R; Cumming DC; De Deuxchaisnes CN; Geusens P; Hosking D; Jaeger P; Kaufman JM; Leite M; Leon J; Liberman U; Menkes CJ; Meunier PJ; Reid I; Rodriguez J; Romanowicz A; Seeman E; Vermeulen A; Hirsch LJ; Lombardi A; Plezia K; Santora AC; Yates AJ; Yuan W
Bone; 1996 Feb; 18(2):141-50. PubMed ID: 8833208
[TBL] [Abstract][Full Text] [Related]
27. Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis.
Reginster JY
Bone Miner; 1993 Dec; 23(3):223-32. PubMed ID: 8148667
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
29. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
30. [Ipriflavone].
Kitatani K; Morii H
Nihon Rinsho; 1998 Jun; 56(6):1537-43. PubMed ID: 9648478
[TBL] [Abstract][Full Text] [Related]
31. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
32. Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists.
Gambacciani M; Cappagli B; Piaggesi L; Ciaponi M; Genazzani AR
Calcif Tissue Int; 1997; 61 Suppl 1():S15-8. PubMed ID: 9263611
[TBL] [Abstract][Full Text] [Related]
33. The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study.
Ravn P; Clemmesen B; Riis BJ; Christiansen C
Bone; 1996 Nov; 19(5):527-33. PubMed ID: 8922653
[TBL] [Abstract][Full Text] [Related]
34. Short-term treatment of Paget's disease of bone with ipriflavone.
Agnusdei D; Camporeale A; Gonnelli S; Gennari C; Baroni MC; Passeri M
Bone Miner; 1992 Oct; 19 Suppl 1():S35-42. PubMed ID: 1422319
[TBL] [Abstract][Full Text] [Related]
35. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
Adami S; Passeri M; Ortolani S; Broggini M; Carratelli L; Caruso I; Gandolini G; Gnessi L; Laurenzi M; Lombardi A
Bone; 1995 Oct; 17(4):383-90. PubMed ID: 8573412
[TBL] [Abstract][Full Text] [Related]
36. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
37. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].
Celi M; Balducci S; Schiappoli A; Caliumi C; Petramala L; Cerci S; Cotesta D; D'Erasmo E; Letizia C
Ann Ital Med Int; 2003; 18(2):89-98. PubMed ID: 12886826
[TBL] [Abstract][Full Text] [Related]
38. Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling.
Chesnut CH; McClung MR; Ensrud KE; Bell NH; Genant HK; Harris ST; Singer FR; Stock JL; Yood RA; Delmas PD
Am J Med; 1995 Aug; 99(2):144-52. PubMed ID: 7625419
[TBL] [Abstract][Full Text] [Related]
39. Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females.
Nakamura S; Morimoto S; Takamoto S; Onishi T; Fukuo K; Koh E; Kitano S; Miyashita Y; Yasuda O; Tamatani M
Calcif Tissue Int; 1992; 51 Suppl 1():S30-4. PubMed ID: 1422983
[TBL] [Abstract][Full Text] [Related]
40. [Effects of warm needle moxibustion on bone mass density and biochemical indexes of bone metabolism in patients of postmenopausal osteoporosis].
Zhao LH; Nong ZN; Zhong X; Pang Y; Liang JS; Li XD; Ye FW
Zhongguo Zhen Jiu; 2008 Dec; 28(12):897-900. PubMed ID: 19127918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
